Which medication is contraindicated for a client experiencing bradycardia after ensuring respiratory status is stable?

• A. Codeine sulfate
• B. Ceftriaxone (Rocephin)
• C. Morphine sulfate
• D. Atropine

Answer: (C)

In the context of bradycardia, certain medications can exacerbate or complicate the condition. Morphine sulfate, an opioid analgesic, has potential side effects that include respiratory depression and bradycardia itself. In patients who are already experiencing a slowed heart rate, the administration of morphine can further decrease both the heart rate and respiratory drive, leading to deleterious effects on the patient’s overall cardiovascular and respiratory status.

On the other hand, atropine is commonly used in clinical settings for the treatment of bradycardia as it works by blocking the vagus nerve's action on the heart, thereby increasing heart rate. Codeine sulfate, while it has similar respiratory effects as morphine, is generally not used for treating bradycardia and does not actively lower heart rates. Ceftriaxone is an antibiotic and does not impact heart rate directly. Understanding the mechanisms of these medications is crucial for making appropriate clinical decisions, particularly in patients with specific cardiovascular concerns.